1832 Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $12.9M | Hold |
|
|||||
|
2020
Q2 | $12.8M | Sell |
|
|||||
|
2020
Q1 | $29.8M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $112M | Buy |
|
|||||
|
2019
Q1 | $6.43M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $180K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $46.3M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $122M | Buy |
|
|||||
|
2014
Q3 | $94.6M | Buy |
|
|||||
|
2014
Q2 | $68.9M | Sell |
|
|||||
|
2014
Q1 | $84.3M | Buy |
|
|||||
|
2013
Q4 | $69.5M | Sell |
|
|||||
|
2013
Q3 | $70M | Buy |
|